Skip to main content
Retour
Watch Compare

Tenaya Therapeutics, Inc.

Qualité des données : 83%
TNYA
Nasdaq Manufacturing Chemicals
0,74 €
▲ 0,02 € (2,14%)
Cap. Boursière: 160,71 M
Prix
0,74 €
Cap. Boursière
160,71 M
Fourchette du Jour
0,71 € — 0,78 €
Fourchette 52 Semaines
0,36 € — 2,35 €
Volume
3 278 957
Ouverture 0,72 €
Moyenne 50J / 200J
0,73 €
1,13% above
Moyenne 50J / 200J
1,02 €
27,22% below

Quick Summary

Points Clés

Negative free cash flow of -68,88 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-99,18%
En dessous de la moyenne du secteur (-53,41%)
ROIC-73,27%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio4,64
Interest CoverageN/A

Valorisation

PE (TTM)
-1,77
En dessous de la moyenne du secteur (-1,48)
P/B Ratio1,94
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -1,8 -1,5
P/B 1,9 1,6
ROE % -99,2 -53,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -90,60 M
ROE -99,18% ROA -79,78%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -68,88 M
ROIC -73,27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,64
Interest Coverage N/A Asset Turnover N/A
Working Capital 48,03 M Tangible Book Value 82,87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,77 Forward P/E N/A
P/B Ratio 1,94 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -42,86%
Market Cap 160,71 M Enterprise Value 104,40 M
Per Share
EPS (Diluted TTM) -0,59 Revenue / Share N/A
FCF / Share -0,32 OCF / Share -0,31
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 76,03%
SBC-Adj. FCF -83,09 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -90,60 M -111,13 M -124,08 M -123,67 M -72,72 M
EPS (Diluted) -0,59 -1,31 -1,68 -2,76 —
Gross Profit — — — — —
Operating Income -93,33 M -115,95 M -131,19 M -125,62 M -72,81 M
EBITDA — — — — —
R&D Expenses 68,61 M 86,74 M 98,04 M 94,54 M 54,39 M
SG&A Expenses — — — — —
D&A 8,44 M 8,47 M 8,69 M 6,47 M 2,96 M
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 146,92 M 119,94 M 170,52 M 278,95 M 314,19 M
Total Liabilities 23,66 M 27,09 M 31,09 M 35,57 M 35,66 M
Shareholders' Equity 123,27 M 92,85 M 139,42 M 243,38 M 278,53 M
Total Debt — — — — —
Cash & Equivalents 100,55 M 4,32 M 45,68 M 95,27 M 38,13 M
Current Assets 105,59 M 67,38 M 111,58 M 193,75 M 255,36 M
Current Liabilities 15,44 M 15,98 M 22,73 M 24,25 M 21,77 M